RKLB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Rocket Lab Corp (RKLB) is not a strong buy at the moment for a beginner investor with a long-term horizon. While the company has significant growth potential in the space industry and has received positive analyst ratings, the current technical indicators, financial performance, and mixed sentiment suggest it is better to hold off on purchasing at this time. The stock's pre-market performance is flat, and there are concerns about profitability and project delays. A patient investor may want to wait for clearer positive signals or improved financial results before committing.
The MACD histogram is negative and expanding, indicating bearish momentum. The RSI is neutral at 32.204, and moving averages are converging, showing no clear trend. The stock is trading near its key support level of 65.699, with resistance levels at 75.421 and 85.143. Overall, the technical outlook is weak.
Strong growth in revenue (47.97% YoY increase in Q3 2025).
Significant contracts, including an $805M award from the Space Development Agency.
Positive analyst ratings with multiple price target increases (e.g., BofA's $120 target).
Hedge funds are significantly increasing their positions in RKLB.
Insider selling has surged by 2217.13% in the last month.
Concerns about valuation and profitability, with a net income drop of -64.85% YoY and negative EPS.
Delays in the Neutron rocket project, which may impact future revenue.
Bearish technical indicators, including negative MACD and flat pre-market performance.
In Q3 2025, revenue increased by 47.97% YoY to $155.08M, and gross margin improved by 38.38% YoY to 36.96%. However, net income dropped by -64.85% YoY to -$18.26M, and EPS fell by -70.00% YoY to -0.03, reflecting ongoing profitability challenges.
Analysts are generally positive on RKLB, with multiple Buy ratings and price target increases. TD Cowen maintains a Buy rating with a $100 target, while BofA raised its target to $120, citing strong growth potential. However, Goldman Sachs remains Neutral with a $69 target, reflecting concerns about valuation and profitability. Overall, sentiment is cautiously optimistic.
